TOKYO, September 19, 2025 – FUJIFILM Holdings Corporation is pleased to announce that its binoculars “FUJINON BINOCULAR TECHNO-STABI TS-L 1640/2040” received the prestigious “Gold Award,” one of the top honors, at the “IDEA (International Design Excellence Awards) 2025” hosted by the Industrial Designers Society of America (IDSA).The broadcast zoom lens “FUJINON HZK14-100mm” and the analog instant camera “instax mini 99™” also received Bronze Awards. Additionally, seven products, including the high-end compact digital camera “FUJIFILM X100VI,” were selected as finalists*1.
The IDEA is an international design award program established in 1980 by the Industrial Designers Society of America (IDSA). It is considered as one of the world’s three major design awards alongside Germany’s “iF Design Award” and “Red Dot Design Award.” The jury reviews entries based on strict criteria including design innovation, user benefits and social impact, and selects Gold, Silver and Bronze award winners. This marks the ninth time a Fujifilm product has won one of IDEA's top awards.
Fujifilm will continue to work on creating designs that not only have beautiful appearance but also realize designs that highlight the function of each product and service, thereby creating new product values.
- *1 Entries that have passed the primary screening to become candidates for Gold, Silver and Bronze awards.
“FUJIFILM X-T50”
- * instax, instax mini 99, instax WIDE 400, and instax mini Link 3 are registered trademarks or trademarks of FUJIFILM Corporation.
- * Revoria XMF is a registered trademark or trademark of FUJIFILM Business Innovation Corporation.
FUJIFILM Holdings Corporation
Design Strategy Office
E-mail : dgi-101-FH-DSO@fujifilm.com
- * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.
- * This news release is issued by FUJIFILM Holdings Corporation in Japan. Fujifilm makes no representation that products on this news release are commercially available in all countries and regions including the US and EU. Approved uses of healthcare products vary by country and region.